Feasibility and Efficacy of Dose Adjusted Melphalan - Prednisone - Bortezomib (MPV) in Elderly Patients ≥ 75 Years of Age with Newly Diagnosed Multiple Myeloma; the Non-Randomised Phase II HOVON 123 Study
| Autor: | Zweegman, Sonja, Levin, Mark-David, Klein, Saskia K. *, De Waal, Esther G.M., Eeltink, Corien M. *, Ypma, Paula F. *, Dijk, Amanda C. *, Westerman, Matthijs *, Deenik, Wendy, Tanis, Bea *, Slee-Valentijn, Monique S. *, Minnema, Monique, Visser-Wisselaar, Heleen *, Stege, Claudia *, van de Donk, Niels W.C.J., Nasserinejad, Kazem *, Sonneveld, Pieter |
|---|---|
| Zdroj: | In Blood 2 December 2016 128(22):3305-3305 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|